Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 1.00 |
| ▸ | HMGCR | P04035 | 6/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.76 |
| ▸ | RECQL | P46063 | 2/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.72 |
| ▸ | USP2 | O75604 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.72 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 1/20 | 0.72 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | PPARG | P37231 | 4/20 | 0.61 |
| ▸ | PPARD | Q03181 | 4/20 | 0.61 |
| ▸ | PPARA | Q07869 | 4/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL411773 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL589727 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL2350399 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL414435 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL13591746 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL588791 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL413076 | 1.00 | PTPN7 (1.00) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL2552308 | 0.98 | PTPN7 (0.96) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL6660811 | 0.98 | PTPN7 (0.96) | PTPN7HMGCRTDP1RECQLALDH1A1 | |
| SCHEMBL18263681 | 0.98 | PTPN7 (0.96) | PTPN7HMGCRTDP1RECQLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610652-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-03 | — | — | EP | claimed |
| WO-2024090998-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | 한국생명공학연구원 | 2024-05-02 | — | — | WO | claimed |
| CN-116042210-A | Quantum dot capable of being directly photoetched, preparation method and application thereof | 宁波杭州湾新材料研究院 | 2023-05-02 | — | — | CN | claimed |
| CN-110041712-B | Preparation method of thermoreversible color-changing composite material based on polydiacetylene and metal organic framework compound | 西北师范大学 | 2021-07-23 | — | — | CN | claimed |
| US-9163307-B2 | Three-dimensional photoresists via functionalization of polymer thin films fabricated by iCVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-10-20 | — | — | US | claimed |
| US-20130260054-A1 | Three-Dimensional Photoresists via Functionalization of Polymer Thin Films Fabricated by iCVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-03 | — | — | US | claimed |
| WO-2013148126-A1 | THREE-DIMENSIONAL PHOTORESISTS VIA FUNCTIONALIZATION OF POLYMER THIN FILMS FABRICATED BY ICVD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-03 | — | — | WO | claimed |
| US-20260055280-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | ISP INVESTMENTS LLC (US) | 2026-02-26 | — | — | US | disclosed |
| EP-4610652-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-03 | — | — | EP | disclosed |
| EP-4416552-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | ISP Investments LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-12031128-B2 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | BATTELLE MEMORIAL INSTITUTE (US) | 2024-07-09 | — | — | US | disclosed |
| WO-2024090998-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | 한국생명공학연구원 | 2024-05-02 | — | — | WO | disclosed |
| US-20240117339-A1 | RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS | BATTELLE MEMORIAL INSTITUTE | 2024-04-11 | — | — | US | disclosed |
| US-20030226978-A1 | Integrating ultraviolet exposure detection devices | SEGAN INDUSTRIES | 2003-12-11 | — | — | US | disclosed |
| WO-2003085397-A2 | PLURAL INTRINSIC EXPIRATION INITIATION APPLICATION INDICATORS | CMC DAYMARK CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |
| US-20030185706-A1 | Plural intrinsic expiration initiation application indicators | CMC Group, Inc. | 2003-10-02 | — | — | US | disclosed |
| US-20030103905-A1 | Methods and compositions for preparing consumables with optical shifting properties | SEGAN INDUSTRIES | 2003-06-05 | — | — | US | disclosed |
| EP-1297333-A2 | INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE | Segan Industries, Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20020034475-A1 | Ingestibles possessing intrinsic color change | SEGAN INDUSTRIES | 2002-03-21 | — | — | US | disclosed |
| WO-2002000920-A2 | INGESTIBLES POSSESSING INTRINSIC COLOR CHANGE | SEGAN INDUSTRIES, INC. (US) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030103905-A1 | Methods and compositions for preparing consumables with optical shifting properties | TAS2R46, THEM6, TAS2R41 | PTPN7 3762/4885HMGCR 4673/4885TDP1 1698/4885 |
| US-20260055280-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | BRCA1, ATR, ATM | PTPN7 2525/4885HMGCR 1408/4885TDP1 2348/4885 |
| US-12031128-B2 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | PHAX, POLRMT, RFTN1 | PTPN7 1723/4885HMGCR 3583/4885TDP1 158/4885 |
| US-20020034475-A1 | Ingestibles possessing intrinsic color change | TAS2R46, THEM6, TAS2R16 | PTPN7 3807/4885HMGCR 4428/4885TDP1 1792/4885 |
| US-20240117339-A1 | RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS | PHAX, POLRMT, RFTN1 | PTPN7 1723/4885HMGCR 3583/4885TDP1 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.